News and Press

ProteinLogic Ltd At Bio€quity 2018, Ghent, Belgium

CAMBRIDGE, UK (2018-05-17) – ProteinLogic attended 19th Bio€quity Europe event, held in Ghent, Belgium. Bio€quity Europe pioneered the turf-neutral concept, creating an open door for all members of the financial community and business development and licensing professionals to do business with independently selected presenting companies. ProteinLogic was invited to present to a panel of investors and…

Read More

ProteinLogic Ltd At BioTrinity 2018, London, UK

CAMBRIDGE, UK (2018-04-26) – ProteinLogic attended BioTrinity 2018, Europe’s leading biopartnering and investment conference. During the event, ProteinLogic delegates took advantage of the partnering environment to provide exposure of our technology, and our validated TB diagnostic to investors and life-sciences key players. The event included panel discussions of significant interest, especially regarding market access globally, the…

Read More

ProteinLogic Appoints Dr Nicolas Huber as Chief Executive Officer

CAMBRIDGE, UK (2018-02-19) – ProteinLogic, the biomarker discovery company, has appointed Dr Nicolas Huber as its Chief Executive Officer. Dr Huber holds a Masters degree in electronic engineering and a PhD in Space Science from the University of Sussex. After working in the aerospace sector he transitioned to the biomedical sciences, and over the past…

Read More

48th Union World Conference on Lung Health in Guadalajara, Mexico

ProteinLogic attended the 48th Union World Conference on Lung Health held in Guadalajara, Mexico, held on 11th-14th October 2017.  The conference theme was  ‘Accelerating Toward Elimination’. There was a focus on how to accelerate toward elimination of Tuberculosis. Numerous prominent scientists and global thought leaders emphasised the need for pro-active steps to find people with…

Read More

ProteinLogic develops a Rule-Out Test for Active TB

CAMBRIDGE, UK (2017-08-30) – ProteinLogic, a biomarker discovery company, funded by a grant by the European Union Horizon 2020 SME programme to develop a rapid point-of-care test for the diagnosis of Active Tuberculosis (TB), has achieved a significant milestone. In 2015, 10.4 million people fell ill with TB and 1.8 million died from the disease….

Read More

ProteinLogic appoints Dr Alex Betz as Chief Scientific Officer

CAMBRIDGE, UK (2016-05-03) – ProteinLogic, the biomarker discovery and exploitation company, has appointed Dr Alex Betz as Chief Scientific Officer to manage the scientific, research, technological and developmental operations. As a long standing non-executive director of the Company, Alex has helped set the company research and scientific priorities so that they line up with the…

Read More

ProteinLogic appoints Dr Roslin Russell as VP Bioinformatics & Computational Biology

ProteinLogic, the biomarker discovery and exploitation company, has appointed Dr Roslin Russell as Vice President of Bioinformatics & Computational Biology to bring technical expertise in the execution of the company’s R&D strategy. Before joining ProteinLogic, Roslin Russell spent eight years working for the Cambridge Institute, Cancer Research UK, as a computational biologist specialising in high-throughput…

Read More

ProteinLogic appoints Mr Damon Parkington as Assay Development & Research Scientist

ProteinLogic, the biomarker discovery and exploitation company, has appointed Mr Damon Parkington as Assay Development and Research Scientist to provide technical leadership in the development of novel immunoassays for research and to bring expertise on relevant clinical instruments to further the company’s R&D and business development strategies. Damon Parkington is an HCPC-registered Biomedical Scientist with…

Read More

ProteinLogic appoints Mr Mahesh Shah as Executive Chairman

ProteinLogic, the biomarker discovery and exploitation company, has appointed Mr Mahesh Shah (MBA) as Executive Chairman to lead the business as it expands into the TB diagnostics space. Mahesh Shah was the founder and CEO of the retail pharmacy business Nucare PLC, a company with operations in the UK as well as overseas. Under his…

Read More